Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-07 Purchase | 2024-02-08 4:30 pm | Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development | 21,000 | $2.4536 | $51,526 | 139,702 (Indirect Direct) | View |
| 2024-02-06 Purchase | 2024-02-07 4:22 pm | Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development | 20,000 | $2.5252 | $50,504 | 118,702 (Indirect Direct) | View |
| 2024-01-31 Purchase | 2024-02-01 6:32 pm | Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off | 4,000 | $2.3813 | $9,525 | 27,478 (Direct) | View |
| 2024-01-30 Purchase | 2024-01-31 4:37 pm | Processa Pharmaceuticals Inc. | PCSA | Ng George K Chief Executive Officer | 10,000 | $2.7 | $27,000 | 20,000 (Indirect) | View |
| 2024-01-30 Purchase | 2024-01-31 4:34 pm | Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director | 8,000 | $2.693 | $21,544 | 34,969 (Indirect Direct) | View |
| 2023-06-12 Purchase | 2023-06-12 4:31 pm | Processa Pharmaceuticals Inc. | PCSA | Young David President & CEO 10% Owner | 40,000 | $0.8 | $32,000 | 1,676,691 (Indirect Direct) | View |
| 2023-04-14 Purchase | 2023-04-14 6:16 pm | Processa Pharmaceuticals Inc. | PCSA | Young David President & CEO 10% Owner | 20,000 | $0.5499 | $10,998 | 1,636,691 (Indirect Direct) | View |
| 2023-04-11 Purchase | 2023-04-13 4:51 pm | Processa Pharmaceuticals Inc. | PCSA | Young David President & CEO 10% Owner | 60,000 | $0.48333 | $29,000 | 1,616,691 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-01 Tax Withholding | 2024-04-12 5:01 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development | 518 | $2.79 | 160,192 (Direct) | View |
| 2024-01-01 Exercise | 2024-04-12 5:01 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development | 1,675 | $0 | 160,192 (Direct) | View |
| 2024-01-01 Tax Withholding | 2024-04-12 4:57 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 518 | $2.79 | 30,157 (Direct) | View |
| 2024-01-01 Exercise | 2024-04-12 4:57 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 1,675 | $0 | 30,157 (Direct) | View |
| 2024-01-01 Tax Withholding | 2024-04-12 4:55 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off | 539 | $2.79 | 48,746 (Direct) | View |
| 2024-01-01 Exercise | 2024-04-12 4:55 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off | 1,675 | $0 | 48,746 (Direct) | View |
| 2024-01-01 Tax Withholding | 2024-04-12 4:52 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Bigora Sian Chief Development Officer | 368 | $2.79 | 50,265 (Direct) | View |
| 2024-01-01 Exercise | 2024-04-12 4:52 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Bigora Sian Chief Development Officer | 1,675 | $0 | 50,265 (Direct) | View |
| 2024-01-01 Tax Withholding | 2024-04-12 4:50 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Guy Wendy Chief Administrative Officer | 368 | $2.79 | 39,900 (Direct) | View |
| 2024-01-01 Exercise | 2024-04-12 4:50 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Guy Wendy Chief Administrative Officer | 1,675 | $0 | 39,900 (Direct) | View |
| 2023-11-21 Other | 2023-11-28 4:13 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director | 55,267 | $0 | 594,619 (Indirect) | View |
| 2023-10-12 Option Award(A) | 2023-10-23 5:31 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director | 6,000 | $0.3 | 594,619 (Direct) | View |
| 2023-10-12 Option Award | 2023-10-12 6:07 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Guy Wendy Chief Administrative Officer | 14,771 | $0.34 | 369,208 (Direct) | View |
| 2023-10-12 Option Award | 2023-10-12 6:04 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Ng George K Chief Executive Officer | 100,000 | $0.25 | 200,000 (Direct) | View |
| 2023-10-12 Option Award | 2023-10-12 6:01 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off | 5,000 | $0.32 | 469,535 (Direct) | View |
| 2023-10-12 Option Award | 2023-10-12 5:58 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 15,000 | $0.33 | 99,250 (Direct) | View |
| 2023-10-12 Option Award | 2023-10-12 5:56 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director | 6,000 | $0.3 | 595,619 (Direct) | View |
| 2023-10-12 Option Award | 2023-10-12 5:54 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development 10% Owner | 155,277 | $0.29 | 1,973,968 (Direct) | View |
| 2023-10-10 Option Award | 2023-10-10 5:05 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Pannu Geraldine Director | 4,500 | $0.21 | 57,613 (Direct) | View |
| 2023-10-10 Option Award | 2023-10-10 5:03 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development 10% Owner | 142,000 | $0.24 | 1,818,691 (Direct) | View |
| 2023-10-10 Option Award | 2023-10-10 5:00 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off | 13,700 | $0.21 | 464,535 (Direct) | View |
| 2023-10-10 Option Award | 2023-10-10 4:58 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director | 12,000 | $0.21 | 589,619 (Direct) | View |
| 2023-10-10 Option Award | 2023-10-10 4:56 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Ng George K Chief Executive Officer | 100,000 | $0.25 | 100,000 (Direct) | View |
| 2023-10-10 Option Award | 2023-10-10 4:51 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 22,500 | $0.24 | 84,250 (Direct) | View |
| 2023-08-08 Option Award | 2023-08-09 4:51 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Ng George K Chief Executive Officer | 800,000 | $0 | 1,200,000 (Direct) | View |
| 2023-06-27 Exercise | 2023-07-24 6:38 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Neal James R Director | 14,407 | $0 | 115,772 (Direct) | View |
| 2023-06-27 Option Award | 2023-07-24 6:38 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Neal James R Director | 101,365 | $0 | 115,772 (Direct) | View |
| 2023-06-27 Exercise | 2023-07-24 6:35 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director | 23,636 | $0 | 677,984 (Direct) | View |
| 2023-06-27 Option Award | 2023-07-24 6:35 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director | 101,365 | $0 | 677,984 (Direct) | View |
| 2023-06-27 Exercise | 2023-07-24 6:33 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | THOMPSON VIRGIL Director | 23,636 | $0 | 241,907 (Direct) | View |
| 2023-06-27 Option Award | 2023-07-24 6:33 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | THOMPSON VIRGIL Director | 101,365 | $0 | 241,907 (Direct) | View |
| 2023-06-27 Exercise | 2023-07-24 6:29 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Baluch Khoso Director | 15,455 | $0 | 129,320 (Direct) | View |
| 2023-06-27 Option Award | 2023-07-24 6:29 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Baluch Khoso Director | 101,365 | $0 | 129,320 (Direct) | View |
| 2023-06-27 Exercise | 2023-07-24 6:26 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Pannu Geraldine Director | 23,636 | $0 | 154,478 (Direct) | View |
| 2023-06-27 Option Award | 2023-07-24 6:26 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Pannu Geraldine Director | 101,365 | $0 | 154,478 (Direct) | View |
| 2023-02-09 Option Award | 2023-02-10 5:22 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Floyd Robert Michael Chief Operating Officer | 10,000 | $0.8 | 172,061 (Direct) | View |
| 2023-02-09 Option Award | 2023-02-10 5:20 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer | 12,500 | $0.8 | 61,750 (Direct) | View |
| 2023-02-09 Option Award | 2023-02-10 5:18 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Baluch Khoso Director | 12,500 | $0.8 | 12,500 (Direct) | View |
| 2023-02-09 Option Award | 2023-02-10 5:09 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off | 12,500 | $0.8 | 450,835 (Direct) | View |
| 2023-02-09 Option Award | 2023-02-10 5:04 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Young David President & CEO 10% Owner | 18,750 | $0.8 | 1,556,691 (Direct) | View |
| 2023-01-01 Option Award | 2023-01-04 5:49 pm | N/A N/A | Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director | 48,208 | $0 | 595,656 (Direct) | View |